BRPI0813309A2 - Capsídeo, mistura de capsídeos, proteína quimérica, métodos para produzir o capsídeo, e para produzir a mistura de capsídeos, e, complexo de hemicianina de lapa e epítopo l2 de papilomavírus humano 16. - Google Patents
Capsídeo, mistura de capsídeos, proteína quimérica, métodos para produzir o capsídeo, e para produzir a mistura de capsídeos, e, complexo de hemicianina de lapa e epítopo l2 de papilomavírus humano 16.Info
- Publication number
- BRPI0813309A2 BRPI0813309A2 BRPI0813309A BRPI0813309A2 BR PI0813309 A2 BRPI0813309 A2 BR PI0813309A2 BR PI0813309 A BRPI0813309 A BR PI0813309A BR PI0813309 A2 BRPI0813309 A2 BR PI0813309A2
- Authority
- BR
- Brazil
- Prior art keywords
- capsid
- mix
- producing
- epype
- hemicyanin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007167154 | 2007-06-26 | ||
| JP2007-167154 | 2007-06-26 | ||
| PCT/JP2008/061569 WO2009001867A1 (ja) | 2007-06-26 | 2008-06-25 | 高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0813309A2 true BRPI0813309A2 (pt) | 2014-12-23 |
| BRPI0813309B1 BRPI0813309B1 (pt) | 2020-10-06 |
| BRPI0813309B8 BRPI0813309B8 (pt) | 2021-05-25 |
Family
ID=40185679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813309A BRPI0813309B8 (pt) | 2007-06-26 | 2008-06-25 | capsídeo, mistura de capsídeos e proteína quimérica |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9023364B2 (pt) |
| EP (1) | EP2168977B1 (pt) |
| JP (1) | JP5540329B2 (pt) |
| KR (2) | KR20150090285A (pt) |
| CN (1) | CN101835796A (pt) |
| AU (1) | AU2008268014B2 (pt) |
| BR (1) | BRPI0813309B8 (pt) |
| CA (1) | CA2691745C (pt) |
| ES (1) | ES2688474T3 (pt) |
| MX (1) | MX2009014246A (pt) |
| MY (1) | MY152175A (pt) |
| NZ (1) | NZ582271A (pt) |
| RU (1) | RU2471807C2 (pt) |
| WO (1) | WO2009001867A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2199301A1 (en) | 2008-12-19 | 2010-06-23 | DKFZ Deutsches Krebsforschungszentrum | Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof |
| EP2416798B1 (en) * | 2009-04-10 | 2017-09-20 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| CA2768172A1 (en) | 2009-06-25 | 2010-12-29 | Glaxosmithkline Biologicals S.A. | Novel compositions |
| SI2585477T1 (sl) * | 2010-06-23 | 2019-03-29 | Deutsches Krebsforschungszentrum | Preurejene tt virusne molekule za uporabo v diagnozi, preprečevanje in zdravljenje raka in avtoimunosti |
| CN103582651A (zh) | 2010-12-27 | 2014-02-12 | 公益财团法人日本健康科学振兴财团 | 识别人类乳突病毒(hpv)l2蛋白质的单克隆抗体及使用其的测定hpv中和抗体的效价的方法 |
| EP2940133A4 (en) * | 2012-12-25 | 2016-07-06 | Chemo Sero Therapeut Res Inst | VACCINE FOR HPV INFECTION AND / OR HEPATITIS B WITH CHIMERIC HPV / HBS PROTEIN AS AN ACTIVE SUBSTANCE |
| CN107188966B (zh) * | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
| CN114716560B (zh) * | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒18型嵌合蛋白及其用途 |
| CN114716562B (zh) * | 2021-01-04 | 2023-11-10 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒58型嵌合蛋白及其用途 |
| CN114716561B (zh) * | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒31型嵌合蛋白及其用途 |
| CN115337388A (zh) * | 2022-07-01 | 2022-11-15 | 南方医科大学 | 一种抗菌和预防hpv病毒的按需释放凝胶及其制备方法 |
| CN115724950B (zh) * | 2022-11-15 | 2023-10-03 | 怡道生物科技(苏州)有限公司 | Hpv6型衣壳蛋白l1单克隆抗体、制备方法及应用 |
| CN116199772B (zh) * | 2022-11-16 | 2023-10-17 | 怡道生物科技(苏州)有限公司 | Hpv31型衣壳蛋白l1单克隆抗体、制备方法及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2189882C (en) | 1994-05-16 | 2005-09-20 | Kathrin U. Jansen | Papillomavirus vaccines |
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| RU2229307C1 (ru) * | 2002-10-22 | 2004-05-27 | ООО "Фирма"БиоМедИнвест" | Композиция рекомбинантных белков, способ получения такой композиции, фармацевтический набор реагентов для иммунотерапии и профилактической вакцинации опухолевых заболеваний аногенитальной сферы, способ иммунотерапии и профилактической вакцинации на его основе |
| WO2005097987A1 (ja) * | 2004-04-09 | 2005-10-20 | Japan Health Sciences Foundation | 粘膜指向性ヒトパピローマウイルス群の感染予防ワクチン抗原 |
| KR20080025171A (ko) | 2005-06-21 | 2008-03-19 | 메드이뮨 백신즈 인코포레이티드 | 이종성 프로테아제를 발현시키기 위한 방법 및 조성물 |
| JP4825958B2 (ja) * | 2005-08-10 | 2011-11-30 | 財団法人ヒューマンサイエンス振興財団 | 高リスク群ヒトパピローマウイルスの中和抗体を誘導する抗原 |
-
2008
- 2008-06-25 CA CA2691745A patent/CA2691745C/en active Active
- 2008-06-25 MX MX2009014246A patent/MX2009014246A/es active IP Right Grant
- 2008-06-25 NZ NZ582271A patent/NZ582271A/en not_active IP Right Cessation
- 2008-06-25 KR KR1020157020314A patent/KR20150090285A/ko not_active Ceased
- 2008-06-25 ES ES08777585.4T patent/ES2688474T3/es active Active
- 2008-06-25 US US12/452,305 patent/US9023364B2/en active Active
- 2008-06-25 WO PCT/JP2008/061569 patent/WO2009001867A1/ja not_active Ceased
- 2008-06-25 MY MYPI20095591 patent/MY152175A/en unknown
- 2008-06-25 JP JP2009520619A patent/JP5540329B2/ja active Active
- 2008-06-25 RU RU2009148037/10A patent/RU2471807C2/ru active
- 2008-06-25 CN CN200880021650A patent/CN101835796A/zh active Pending
- 2008-06-25 KR KR1020097026877A patent/KR101624358B1/ko not_active Expired - Fee Related
- 2008-06-25 AU AU2008268014A patent/AU2008268014B2/en not_active Ceased
- 2008-06-25 EP EP08777585.4A patent/EP2168977B1/en active Active
- 2008-06-25 BR BRPI0813309A patent/BRPI0813309B8/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2688474T3 (es) | 2018-11-02 |
| US9023364B2 (en) | 2015-05-05 |
| EP2168977A4 (en) | 2013-12-18 |
| CN101835796A (zh) | 2010-09-15 |
| MX2009014246A (es) | 2010-03-31 |
| EP2168977A1 (en) | 2010-03-31 |
| AU2008268014B2 (en) | 2013-10-31 |
| KR20150090285A (ko) | 2015-08-05 |
| AU2008268014A1 (en) | 2008-12-31 |
| EP2168977B1 (en) | 2018-08-08 |
| BRPI0813309B8 (pt) | 2021-05-25 |
| CA2691745C (en) | 2017-08-15 |
| US20100183648A1 (en) | 2010-07-22 |
| NZ582271A (en) | 2012-03-30 |
| BRPI0813309B1 (pt) | 2020-10-06 |
| WO2009001867A1 (ja) | 2008-12-31 |
| JPWO2009001867A1 (ja) | 2010-08-26 |
| KR101624358B1 (ko) | 2016-05-26 |
| MY152175A (en) | 2014-08-15 |
| KR20100029216A (ko) | 2010-03-16 |
| JP5540329B2 (ja) | 2014-07-02 |
| CA2691745A1 (en) | 2008-12-31 |
| RU2471807C2 (ru) | 2013-01-10 |
| RU2009148037A (ru) | 2011-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0813309A2 (pt) | Capsídeo, mistura de capsídeos, proteína quimérica, métodos para produzir o capsídeo, e para produzir a mistura de capsídeos, e, complexo de hemicianina de lapa e epítopo l2 de papilomavírus humano 16. | |
| IL258718A (en) | Human anti-il-23 antibodies,compositions, methods and uses | |
| LTPA2017011I1 (lt) | Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui | |
| EP1912667A4 (en) | CONCENTRATED PROTEIN LYOPHILISATES, ASSOCIATED METHODS AND USES THEREOF | |
| BRPI0817923A2 (pt) | Implemento para cuidado oral, e, método | |
| IL184175A (en) | Sulfonyl pyrrolidines, method for producing the same and their use as drugs | |
| NO2017005I1 (no) | Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58] | |
| IL191759A (en) | Ganaxolone formulations and methods for the making and use thereof | |
| BRPI0717041A2 (pt) | produto alimentÍcio gaseificado, e, mÉtodo para preparar o mesmo | |
| IL180682A0 (en) | N-hydroxamide derivatives, their preparation and use | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BRPI0718192A2 (pt) | Corantes dispersos, sua preparação e seu uso. | |
| DK2051975T3 (da) | Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel. | |
| EG25359A (en) | Disposable diaper. | |
| BRPI0806589A2 (pt) | Catalisador, sua preparação e uso. | |
| IL187392A0 (en) | Thiazole derivatives, their preparation and use | |
| IL184314A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
| DK1768833T3 (da) | Formlegeme, fremgangsmåde til dets fremstilling samt dets anvendelse | |
| GB0420062D0 (en) | Assay methods,materials and preparations | |
| IL190519A0 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
| FI20055470L (fi) | Menetelmä maitotuotteiden valmistamiseksi, näin saadut tuotteet ja niiden käyttö | |
| NO344962B1 (no) | Amorf cesiumaluminiumfluorklompleks, dets fremstilling og bruk | |
| DK1753725T3 (da) | Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf. | |
| SI2020410T1 (sl) | Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba | |
| DE602005002294D1 (de) | Druckplattenmaterial, Druckplatte und Druckverfahren. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B25G | Requested change of headquarter approved |
Owner name: JAPAN HEALTH SCIENCES FOUNDATION (JP) |
|
| B25A | Requested transfer of rights approved |
Owner name: JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES (JP) |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2832 DE 15-04-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |